Rituximab Combined With Prior Therapy in Advanced Hepatocellular Carcinoma: Efficacy & Safety Study
Conditions: Advanced Hepatocellular Carcinoma Interventions: Drug: Rituximab+PD-1 or PD-L1 inhibitors+targeted therapy Sponsors: Tianjin Medical University Cancer Institute and Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Hospitals | Liver Cancer | Research | Rituxan | Study